Revance Therapeutics News

Revance Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 16:26 ET

Revance Therapeutics | 8-K: Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update

Nov 7 16:21 ET

Revance Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 16:40 ET

Revance Therapeutics | 8-K: Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update

Aug 8 16:10 ET

Revance Therapeutics | 10-Q: Q1 2024 Earnings Report

May 9 16:42 ET

Revance Therapeutics | 8-K: Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update

May 9 16:16 ET

Revance Therapeutics | 10-K: FY2023 Annual Report

Feb 28 22:37 ET

Revance Therapeutics | 8-K: Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update

Feb 28 16:15 ET

Revance Therapeutics | 8-K: Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook

Jan 8 00:00 ET

Revance Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 8, 2023 16:33 ET

Revance Therapeutics | 8-K: Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update

Nov 8, 2023 16:09 ET

Revance Therapeutics | 10-Q: Q2 2023 Earnings Report

Aug 8, 2023 16:34 ET

Revance Therapeutics | 8-K: Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update

Aug 8, 2023 16:08 ET

Revance Therapeutics | 10-Q: Q1 2023 Earnings Report

May 9, 2023 16:34 ET

Revance Therapeutics | 8-K: Revance Reports First Quarter 2023 Financial Results, Provides Corporate Update

May 9, 2023 16:07 ET

Revance Therapeutics | 10-K: FY2022 Annual Report

Feb 28, 2023 16:22 ET

Revance Therapeutics | 8-K: Revance Reports Fourth Quarter and Full Year 2022 Financial Results, Provides Corporate Update

Feb 28, 2023 16:10 ET

Revance Therapeutics | 8-K: Revance Provides an Update on DAXXIFY® Commercial Launch and Preliminary Fourth Quarter and Full Year 2022 Financial Results

Jan 9, 2023 08:02 ET

Revance Therapeutics | 10-Q: Q3 2022 Earnings Report

Nov 8, 2022 16:32 ET

Revance Therapeutics | 8-K: Revance Reports Third Quarter 2022 Financial Results, Provides Corporate Update

Nov 8, 2022 16:06 ET